Clinical symptoms, diagnosis and outcome of encephalopathy
DOI:
https://doi.org/10.18203/2394-6040.ijcmph20243795Keywords:
Clinical symptoms, Encephalopathy, DiagnosisAbstract
Encephalopathy comprises a range of neurological syndromes caused by several etiologies, including metabolic, toxic, structural, and infectious factors. These conditions share common clinical features such as altered mental status, seizures, and cognitive deficits, making diagnosis challenging. Subtypes include reversible forms, like hepatic encephalopathy and posterior reversible encephalopathy syndrome, and progressive forms, like chronic traumatic encephalopathy. Accurate diagnosis requires comprehensive evaluation, integrating clinical assessments and advanced imaging techniques. Management strategies vary widely, emphasizing underlying cause resolution and symptom control. Advances in diagnostic tools and tailored therapeutic strategies have improved outcomes for certain subtypes but underscore the need for early recognition and precise differentiation. Ongoing research and multidisciplinary efforts are essential to address knowledge gaps, refine management, and enhance quality of life for affected individuals. This review highlights diagnostic challenges, therapeutic approaches, and outcomes, underscoring the importance of individualized care for optimizing prognoses in these multifaceted conditions.
Metrics
References
Erkkinen MG, Berkowitz AL. A clinical approach to diagnosing encephalopathy. Am J Med. 2019;132(10):1142-7.
Koksel Y, McKinney AM. Potentially reversible and recognizable acute encephalopathic syndromes: Disease categorization and MRI appearances. AJNR Am J Neuroradiol. 2020;41(8):1328-38.
Gabriel MM, Kircheis G, Hardtke S, Markwardt D, Buggisch P, Mix H, et al. Risk of recurrent hepatic encephalopathy in patients with liver cirrhosis: a German registry study. Eur J Gastroenterol Hepatol. 2021;33(9):1185-93.
Triplett JD, Kutlubaev MA, Kermode AG, Hardy T. Posterior reversible encephalopathy syndrome (PRES): diagnosis and management. Pract Neurol. 2022;22(3):183-9.
Imataka G, Kuwashima S, Yoshihara S. A comprehensive review of pediatric acute encephalopathy. J Clin Med. 2022;11(19):10.
Alosco ML, Stern RA. The long-term consequences of repetitive head impacts: Chronic traumatic encephalopathy. Handb Clin Neurol. 2019;167:337-55.
Franks JA, Anderson JL, Bowman E, Li CY, Kennedy RE, Yun H. Inpatient diagnosis of delirium and encephalopathy: Coding trends in 2011-2018. J Acad Consult Liaison Psychiatry. 2022;63(5):413-22.
Sutter R, Semmlack S, Kaplan PW. Nonconvulsive status epilepticus in adults - insights into the invisible. Nat Rev Neurol. 2016;12(5):281-93.
Jissendi Tchofo P. CT scan and MRI applications in the field of neuroimaging. Rev Med Brux. 2018;39(4):214-9.
Fallahzadeh MA, Rahimi RS. Hepatic encephalopathy: Current and emerging treatment modalities. Clin Gastroenterol Hepatol. 2022;20(8S):S9-19.
Li K, Wang L, Liu G, Jin P, Fan C, Zhang T, et al. Different dosages of methylprednisolone therapy for acute necrotizing encephalopathy of childhood: a 6-year multicenter retrospective study. Chin Med J (Engl). 2023;136(6):743-5.
Walker V. Severe hyperammonaemia in adults not explained by liver disease. Ann Clin Biochem. 2012;49(Pt 3):214-28.
Krzyzaniak K, Krion R, Szymczyk A, Stepniewska E, Sieminski M. Exploring neuroprotective agents for sepsis-associated encephalopathy: A comprehensive review. Int J Mol Sci. 2023;24(13):10780.
Weissenborn K. Hepatic encephalopathy: Definition, clinical grading and diagnostic principles. Drugs. 2019;79(1):5-9.
Rudler M, Weiss N, Bouzbib C, Thabut D. Diagnosis and management of hepatic encephalopathy. Clin Liver Dis. 2021;25(2):393-417.
Vilstrup H, Amodio P, Bajaj J, Cordoba J, Ferenci P, Mullen KD, et al. Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver. Hepatology. 2014;60(2):715-35.
Bajaj JS, Kassam Z, Fagan A, Gavis EA, Liu E, Cox IJ, et al. Fecal microbiota transplant from a rational stool donor improves hepatic encephalopathy: A randomized clinical trial. Hepatology. 2017;66(6):1727-38.
Weissenborn K, Ennen JC, Schomerus H, Ruckert N, Hecker H. Neuropsychological characterization of hepatic encephalopathy. J Hepatol. 2001;34(5):768-73.
Labenz C, Beul L, Toenges G, Schattenberg JM, Nagel M, Sprinzl MF, et al. Validation of the simplified Animal Naming Test as primary screening tool for the diagnosis of covert hepatic encephalopathy. Eur J Intern Med. 2019;60:96-100.
Jepsen P, Ott P, Andersen PK, Sorensen HT, Vilstrup H. Clinical course of alcoholic liver cirrhosis: a Danish population-based cohort study. Hepatology. 2010;51(5):1675-82.
Shaw J, Bajaj JS. Covert hepatic encephalopathy: Can my patient drive? J Clin Gastroenterol. 2017;51(2):118-26.
Wijdicks EF. Hepatic encephalopathy. N Engl J Med. 2016;375(17):1660-70.
Rosner MH, Husain-Syed F, Reis T, Ronco C, Vanholder R. Uremic encephalopathy. Kidney Int. 2022;101(2):227-41.
Yanai A, Uchiyama K, Ishibashi Y. Uremic encephalopathy in patients undergoing assisted peritoneal dialysis: a case series and literature review. CEN Case Rep. 2019;8(4):271-9.
Seifter JL, Samuels MA. Uremic encephalopathy and other brain disorders associated with renal failure. Semin Neurol. 2011;31(2):139-43.
Chaudhry N, Duggal AK. Sepsis associated encephalopathy. Adv Med. 2014;2014:762320.
Ren C, Yao RQ, Zhang H, Feng YW, Yao YM. Sepsis-associated encephalopathy: a vicious cycle of immunosuppression. J Neuroinflammation. 2020;17(1):14.
Luetz A, Heymann A, Radtke FM, Chenitir C, Neuhaus U, Nachtigall I, et al. Different assessment tools for intensive care unit delirium: which score to use? Crit Care Med. 2010;38(2):409-18.
Radtke FM, Franck M, Oppermann S, Lutz A, Seeling M, Heymann A, et al. The Intensive Care Delirium Screening Checklist (ICDSC)--translation and validation of intensive care delirium checklist in accordance with guidelines. Anasthesiol Intensivmed Notfallmed Schmerzther. 2009;44(2):80-6.
Marcantonio ER, Ngo LH, O'Connor M, Jones RN, Crane PK, Metzger ED, et al. 3D-CAM: derivation and validation of a 3-minute diagnostic interview for CAM-defined delirium: a cross-sectional diagnostic test study. Ann Intern Med. 2014;161(8):554-61.
Tauber SC, Djukic M, Gossner J, Eiffert H, Bruck W, Nau R. Sepsis-associated encephalopathy and septic encephalitis: an update. Expert Rev Anti Infect Ther. 2021;19(2):215-31.
Nitchingham A, Kumar V, Shenkin S, Ferguson KJ, Caplan GA. A systematic review of neuroimaging in delirium: predictors, correlates and consequences. Int J Geriatr Psychiatry. 2018;33(11):1458-78.
Norton L, Kazazian K, Gofton T, Debicki DB, Fernandez-Espejo D, Peelle JE, et al. Functional neuroimaging as an assessment tool in critically ill patients. Ann Neurol. 2023;93(1):131-41.
Narayanaswami V, Dahl K, Bernard-Gauthier V, Josephson L, Cumming P, Vasdev N. Emerging PET radiotracers and targets for imaging of neuroinflammation in neurodegenerative diseases: Outlook beyond TSPO. Mol Imaging. 2018;17:1536012118792317.
Hosokawa K, Gaspard N, Su F, Oddo M, Vincent JL, Taccone FS. Clinical neurophysiological assessment of sepsis-associated brain dysfunction: a systematic review. Crit Care. 2014;18(6):674.
Gilmore EJ, Gaspard N, Choi HA, Cohen E, Burkart KM, Chong DH, et al. Acute brain failure in severe sepsis: a prospective study in the medical intensive care unit utilizing continuous EEG monitoring. Intensive Care Med. 2015;41(4):686-94.
Pierrakos C, Attou R, Decorte L, Kolyviras A, Malinverni S, Gottignies P, et al. Transcranial Doppler to assess sepsis-associated encephalopathy in critically ill patients. BMC Anesthesiol. 2014;14:45.
Molnar L, Fulesdi B, Nemeth N, Molnar C. Sepsis-associated encephalopathy: A review of literature. Neurol India. 2018;66(2):352-61.
Geocadin RG. Posterior reversible encephalopathy syndrome. N Engl J Med. 2023;388(23):2171-8.
Fugate JE, Rabinstein AA. Posterior reversible encephalopathy syndrome: clinical and radiological manifestations, pathophysiology, and outstanding questions. Lancet Neurol. 2015;14(9):914-25.
Halbach SM, Stein D. Posterior reversible encephalopathy syndrome in children and adolescents. Curr Hypertens Rep. 2024;26(8):349-54.
Liman TG, Siebert E, Endres M. Posterior reversible encephalopathy syndrome. Curr Opin Neurol. 2019;32(1):25-35.
Liman TG, Bohner G, Endres M, Siebert E. Discharge status and in-hospital mortality in posterior reversible encephalopathy syndrome. Acta Neurol Scand. 2014;130(1):34-9.
Burnett MM, Hess CP, Roberts JP, Bass NM, Douglas VC, Josephson SA. Presentation of reversible posterior leukoencephalopathy syndrome in patients on calcineurin inhibitors. Clin Neurol Neurosurg. 2010;112(10):886-91.
Chen Z, Zhang G, Lerner A, Wang AH, Gao B, Liu J. Risk factors for poor outcome in posterior reversible encephalopathy syndrome: systematic review and meta-analysis. Quant Imaging Med Surg. 2018;8(4):421-32.
Laurent C, Capron J, Quillerou B, Thomas G, Alamowitch S, Fain O, et al. Steroid-responsive encephalopathy associated with autoimmune thyroiditis (SREAT): Characteristics, treatment and outcome in 251 cases from the literature. Autoimmun Rev. 2016;15(12):1129-33.
Chaudhuri J, Mukherjee A, Chakravarty A. Hashimoto's encephalopathy: Case series and literature review. Curr Neurol Neurosci Rep. 2023;23(4):167-75.
Grani G, Carbotta G, Nesca A, D'Alessandri M, Vitale M, Del Sordo M, et al. A comprehensive score to diagnose Hashimoto's thyroiditis: a proposal. Endocrine. 2015;49(2):361-5.
Zhou JY, Xu B, Lopes J, Blamoun J, Li L. Hashimoto encephalopathy: literature review. Acta Neurol Scand. 2017;135(3):285-90.
Hosoi Y, Kono S, Terada T, Konishi T, Miyajima H. Hashimoto's encephalopathy associated with an elevated intrathecal IgG4 level. J Neurol. 2013;260(4):1174-6.
VanItallie TB. Traumatic brain injury (TBI) in collision sports: Possible mechanisms of transformation into chronic traumatic encephalopathy (CTE). Metabolism. 2019;100S:153943.
Pierre K, Dyson K, Dagra A, Williams E, Porche K, Lucke-Wold B. Chronic traumatic encephalopathy: Update on current clinical diagnosis and management. Biomedicines. 2021;9(4):10.
McKee AC, Stein TD, Huber BR, Crary JF, Bieniek K, Dickson D, et al. Chronic traumatic encephalopathy (CTE): criteria for neuropathological diagnosis and relationship to repetitive head impacts. Acta Neuropathol. 2023;145(4):371-94.
Bergauer A, van Osch R, van Elferen S, Gyllvik S, Venkatesh H, Schreiber R. The diagnostic potential of fluid and imaging biomarkers in chronic traumatic encephalopathy (CTE). Biomed Pharmacother. 2022;146:112602.
Hugon J, Hourregue C, Cognat E, Lilamand M, Porte B, Mouton-Liger F, et al. Chronic traumatic encephalopathy. Neurochirurgie. 2021;67(3):290-4.
Wu X, Wu W, Pan W, Wu L, Liu K, Zhang HL. Acute necrotizing encephalopathy: an underrecognized clinicoradiologic disorder. Mediators Inflamm. 2015;2015:792578.
Shukla P, Mandalla A, Elrick MJ, Venkatesan A. Clinical manifestations and pathogenesis of acute necrotizing encephalopathy: The interface between systemic infection and neurologic injury. Front Neurol. 2021;12:628811.
Hernandez R, Ota R, Medina Y, Hernandez Y, Julayanont P, Wilms H. Acute necrotizing encephalopathy. Proc (Bayl Univ Med Cent). 2022;35(5):725-7.
Qin N, Wang J, Peng X, Wang L. Pathogenesis and management of acute necrotizing encephalopathy. Expert Rev Neurother. 2023;23(7):641-50.
Chang HP, Hsia SH, Lin JJ, Chan OW, Chiu CC, Lee EP. Early high-dose methylprednisolone therapy Is associated with better outcomes in children with acute necrotizing encephalopathy. Children (Basel). 2022;9(2):136.
Downloads
Published
How to Cite
Issue
Section
